(NASDAQ: CNSY) Cerenome's forecast annual revenue growth rate of 103.37% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.78%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.88%.
Cerenome's revenue in 2026 is $5,182,000.On average, 6 Wall Street analysts forecast CNSY's revenue for 2026 to be $44,196,424, with the lowest CNSY revenue forecast at $26,981,776, and the highest CNSY revenue forecast at $76,085,854. On average, 6 Wall Street analysts forecast CNSY's revenue for 2027 to be $134,385,762, with the lowest CNSY revenue forecast at $67,454,439, and the highest CNSY revenue forecast at $202,363,316.
In 2028, CNSY is forecast to generate $318,109,627 in revenue, with the lowest revenue forecast at $270,960,351 and the highest revenue forecast at $368,590,326.